Work

Cost–Effectiveness of Everolimus- Versus Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization (from the SPIRIT-IV Trial)

Year: 2012

Type: article

Source: The American Journal of Cardiology

DOI: 10.1016/j.amjcard.2012.05.006

Authors: Amit P. Amin, Matthew R. Reynolds, Yang Lei, Elizabeth A. Magnuson, Katherine Vilain, Amy J. Durtschi, Charles A. Simonton, Gregg W. Stone, David J. Cohen

Institutions: Saint Luke's Hospital, University of Missouri–Kansas City, Harvard University, VA Boston Healthcare System, Baim Institute for Clinical Research, Abbott Vascular (United States), NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, Cardiovascular Research Foundation

Language: English

Topic: Coronary Interventions and Diagnostics

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Sanofi, Medtronic, Edwards Lifesciences, Schering-Plough, Boston Scientific Corporation, Daiichi-Sankyo, Abbott Vascular

OpenAlex ID: W2117118143

FWCI: 1.629

Cites: 15

Cited by: 11

Related to: 10